To better elucidate the role of SFRP1 in CRLM, we employed several preclinical models, including subcutaneous tumor, patient derived organoids (PDOs), patient derived xenografts (PDXs), and orthotopic colorectal cancer metastasis models. Here, SFRP1 is linked to neoplasm.